GCTK subsidiary Lōkahi expands ai² platform into three divisions
Lōkahi Therapeutics Inc., a subsidiary of Glucotrack Inc. (NASDAQ: GCTK), said it is expanding its ai² platform into three business divisions: ai² Pipeline™, ai² Talent™, and ai² Accelerator™.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.